Variant report

Variant	nsv883200
Chromosome Location	chr5:177665342-177717640
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:81)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:81 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr5:177705531..177707369-chr5:177709194..177711179,2	K562	blood:
2	chr5:177687306..177690029-chr5:177710452..177712944,2	MCF-7	breast:
3	chr5:177674781..177677713-chr5:177688724..177690382,2	MCF-7	breast:
4	chr5:177708522..177710701-chr5:178921263..178923252,2	K562	blood:
5	chr5:177711262..177713782-chr5:177716663..177718349,2	K562	blood:
6	chr5:177682641..177685103-chr5:177687845..177689639,2	K562	blood:
7	chr5:177673184..177676409-chr5:177679568..177684017,5	K562	blood:
8	chr5:177680211..177682699-chr5:177684964..177686597,2	K562	blood:
9	chr5:177694652..177698387-chr5:177701947..177705005,3	MCF-7	breast:
10	chr5:177543150..177544003-chr5:177676886..177677587,2	MCF-7	breast:
11	chr5:177688646..177691134-chr5:177692615..177694812,2	MCF-7	breast:
12	chr5:177711262..177713126-chr5:177716170..177718163,3	K562	blood:
13	chr5:177706927..177707599-chr5:177977871..177978610,3	MCF-7	breast:
14	chr5:177706663..177708953-chr5:178261165..178263624,2	MCF-7	breast:
15	chr5:177695402..177698313-chr5:177774135..177775779,2	K562	blood:
16	chr5:177674781..177677713-chr5:177688724..177690382,2	MCF-7	breast:
17	chr5:177698904..177700407-chr5:177706155..177707702,2	K562	blood:
18	chr5:177714990..177717211-chr5:177717437..177719265,2	MCF-7	breast:
19	chr5:177664686..177666446-chr5:177667061..177669063,2	MCF-7	breast:
20	chr5:177706996..177707580-chr5:177887844..177888573,2	K562	blood:
21	chr5:177706688..177707297-chr5:177977028..177977867,2	MCF-7	breast:
22	chr5:177667122..177671581-chr5:177672725..177675759,6	K562	blood:
23	chr5:177706637..177707790-chr5:178017212..178018303,12	K562	blood:
24	chr5:177710796..177711682-chr5:178266072..178266614,2	K562	blood:
25	chr5:177663620..177664167-chr5:177676965..177677513,2	MCF-7	breast:
26	chr5:177712144..177714829-chr5:177719190..177721304,2	MCF-7	breast:
27	chr5:177712048..177714602-chr5:177804410..177806425,2	MCF-7	breast:
28	chr5:177669025..177670554-chr5:177680553..177683380,2	MCF-7	breast:
29	chr5:177680211..177682699-chr5:177684964..177686597,2	K562	blood:
30	chr5:177707050..177707576-chr5:177733039..177733583,2	MCF-7	breast:
31	chr5:177658397..177661582-chr5:177665181..177668920,4	MCF-7	breast:
32	chr5:177710809..177711655-chr5:177978098..177978611,2	MCF-7	breast:
33	chr5:177700241..177704563-chr5:177705321..177708218,5	MCF-7	breast:
34	chr5:177698904..177700407-chr5:177706155..177707702,2	K562	blood:
35	chr5:177658492..177661017-chr5:177701580..177703752,2	MCF-7	breast:
36	chr5:177682472..177686138-chr5:177686968..177690671,4	K562	blood:
37	chr5:177666154..177668382-chr5:177684774..177687012,2	MCF-7	breast:
38	chr5:177705017..177707369-chr5:177709194..177712378,3	K562	blood:
39	chr5:177714990..177717211-chr5:177717437..177719265,2	MCF-7	breast:
40	chr5:177671586..177674457-chr5:177675153..177677148,2	MCF-7	breast:
41	chr5:177664512..177669563-chr5:177672713..177676620,5	K562	blood:
42	chr5:177694652..177698387-chr5:177701947..177705005,3	MCF-7	breast:
43	chr5:177679941..177681664-chr5:178053497..178055098,2	K562	blood:
44	chr5:177663359..177666352-chr5:177692543..177695366,2	K562	blood:
45	chr5:177705531..177707369-chr5:177709194..177711179,2	K562	blood:
46	chr5:177673184..177676409-chr5:177679568..177684017,5	K562	blood:
47	chr5:177706726..177707270-chr5:178157310..178157911,2	MCF-7	breast:
48	chr5:177623727..177624647-chr5:177706685..177707211,2	K562	blood:
49	chr5:177637291..177640571-chr5:177674983..177676979,3	K562	blood:
50	chr5:177706743..177707559-chr5:178017553..178018241,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000197451	chromatin interactions
ENSG00000169131	chromatin interactions
ENSG00000242341	chromatin interactions
ENSG00000113240	chromatin interactions
ENSG00000050767	chromatin interactions
ENSG00000182718	chromatin interactions
ENSG00000175309	chromatin interactions

Extended variants
information (count: 2482 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:2482 , 50 per page) page: 1 2 3 4 5 6 7 ... 50

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1544926	chr5:177665342-177665343	Weak transcription Genic enhancers Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs111977623	chr5:177665409-177665410	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs182297389	chr5:177665432-177665433	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs373060611	chr5:177665433-177665434	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs536084994	chr5:177665440-177665441	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs553580259	chr5:177665453-177665454	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs1544925	chr5:177665486-177665487	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs539022515	chr5:177665491-177665492	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs557802075	chr5:177665512-177665513	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs576377093	chr5:177665531-177665532	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs11740043	chr5:177665532-177665533	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs543726320	chr5:177665546-177665547	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs189000256	chr5:177665547-177665548	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs58562702	chr5:177665554-177665555	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs573752756	chr5:177665590-177665591	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs541226510	chr5:177665623-177665624	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs199586986	chr5:177665662-177665663	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs193029360	chr5:177665665-177665666	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs545766417	chr5:177665666-177665667	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs201979754	chr5:177665727-177665728	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs10061163	chr5:177665731-177665732	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs151176062	chr5:177665732-177665733	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs372303892	chr5:177665740-177665741	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs377130455	chr5:177665741-177665742	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs369876153	chr5:177665750-177665751	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs568779477	chr5:177665751-177665752	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs529419384	chr5:177665753-177665754	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs112715515	chr5:177665773-177665774	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs372951332	chr5:177665784-177665785	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs576838321	chr5:177665804-177665805	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs558221220	chr5:177665818-177665819	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs140073989	chr5:177665940-177665941	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs557922428	chr5:177665951-177665952	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs185768350	chr5:177665954-177665955	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs78245912	chr5:177665955-177665956	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs370429416	chr5:177665962-177665963	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs573891171	chr5:177666024-177666025	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs534485599	chr5:177666033-177666034	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs375858049	chr5:177666105-177666106	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs73336873	chr5:177666112-177666113	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs372652212	chr5:177666113-177666114	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs34454955	chr5:177666128-177666129	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs201074844	chr5:177666141-177666142	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs564278854	chr5:177666169-177666170	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs377129986	chr5:177666171-177666172	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs369316274	chr5:177666172-177666173	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs149869133	chr5:177666193-177666194	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs373085209	chr5:177666254-177666255	Enhancers Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs562202230	chr5:177666261-177666262	Enhancers Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs189793454	chr5:177666277-177666278	Enhancers Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:668 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:177659800-177665800	Weak transcription	Gastric	stomach
2	chr5:177660200-177665800	Enhancers	Primary T cells fromperipheralblood	blood
3	chr5:177660200-177667000	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr5:177660200-177667000	Weak transcription	Muscle Satellite Cultured Cells	--
5	chr5:177660200-177667600	Enhancers	Fetal Muscle Trunk	muscle
6	chr5:177660400-177665800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
7	chr5:177660400-177665800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr5:177660400-177666200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
9	chr5:177660400-177668000	Enhancers	Primary hematopoietic stem cells	blood
10	chr5:177661200-177666400	Enhancers	Rectal Mucosa Donor 29	rectum
11	chr5:177661400-177666200	Enhancers	Breast Myoepithelial Primary Cells	Breast
12	chr5:177661400-177667800	Enhancers	Adipose Nuclei	Adipose
13	chr5:177661400-177669600	Enhancers	Primary monocytes fromperipheralblood	blood
14	chr5:177661600-177666400	Enhancers	Fetal Muscle Leg	muscle
15	chr5:177661600-177671600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
16	chr5:177661800-177665400	Enhancers	Spleen	Spleen
17	chr5:177661800-177666400	Enhancers	Duodenum Mucosa	Duodenum
18	chr5:177661800-177666600	Enhancers	Rectal Mucosa Donor 31	rectum
19	chr5:177661800-177667600	Enhancers	Liver	Liver
20	chr5:177661800-177669800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
21	chr5:177662000-177665600	Enhancers	Pancreas	Pancrea
22	chr5:177662200-177665400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
23	chr5:177662200-177665400	Weak transcription	HUES6 Cell Line	embryonic stem cell
24	chr5:177662200-177665600	Weak transcription	Primary T cells from cord blood	blood
25	chr5:177662200-177674800	Weak transcription	Cortex derived primary cultured neurospheres	brain
26	chr5:177662600-177665800	Weak transcription	Thymus	Thymus
27	chr5:177662600-177667600	Weak transcription	Dnd41	blood
28	chr5:177662600-177669600	Weak transcription	Brain Inferior Temporal Lobe	brain
29	chr5:177663000-177665600	Enhancers	Primary neutrophils fromperipheralblood	blood
30	chr5:177663200-177665600	Enhancers	Stomach Mucosa	stomach
31	chr5:177663200-177667600	Enhancers	Left Ventricle	heart
32	chr5:177663400-177665800	Enhancers	HepG2	liver
33	chr5:177663400-177666000	Enhancers	GM12878-XiMat	blood
34	chr5:177663400-177666800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
35	chr5:177663400-177666800	Enhancers	Right Atrium	heart
36	chr5:177663400-177667800	Enhancers	Primary T helper naive cells from peripheral blood	blood
37	chr5:177663400-177668400	Enhancers	Primary T helper cells fromperipheralblood	blood
38	chr5:177663400-177669200	Enhancers	Colonic Mucosa	Colon
39	chr5:177663600-177666400	Enhancers	Brain Hippocampus Middle	brain
40	chr5:177663600-177666600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
41	chr5:177663600-177667200	Enhancers	Sigmoid Colon	Sigmoid Colon
42	chr5:177663600-177667200	Enhancers	HMEC	breast
43	chr5:177663600-177668400	Enhancers	Primary T killer memory cells from peripheral blood	blood
44	chr5:177663600-177669000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
45	chr5:177663800-177665400	Weak transcription	Fetal Stomach	stomach
46	chr5:177663800-177666600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
47	chr5:177663800-177666600	Enhancers	NHEK	skin
48	chr5:177663800-177667000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr5:177663800-177667600	Enhancers	Fetal Thymus	thymus
50	chr5:177663800-177667800	Enhancers	Primary T helper cells PMA-I stimulated	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links